Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)

NCT05683249 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: NRCT-101-SR
DRUG: Placebo

Sponsor

Neurocentria, Inc.